SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 429.05 |
| Enterprise Value ($M) | 332.97 |
| Book Value ($M) | 193.69 |
| Book Value / Share | 3.96 |
| Price / Book | 2.22 |
| NCAV ($M) | -49.03 |
| NCAV / Share | -1.00 |
| Price / NCAV | -8.75 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.19 |
| Return on Assets (ROA) | -0.11 |
| Return on Equity (ROE) | -0.19 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.20 |
| Current Ratio | 5.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 119.31 |
| Assets | 362.03 |
| Liabilities | 168.34 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 7.60 | ||
| 13G/A | Baupost Group Llc/ma | 0.00 | -100.00 | |
| 13G | Newtyn Management, LLC | 8.40 | ||
| 13G/A | Odre 2005 Slu | 0.00 | -100.00 | |
| 13G/A | Madison Avenue Partners, LP | 17.50 | 21.38 | |
| 13D/A | Weiss Asset Management LP | |||
| 13G | Irenic Capital Management LP | 5.50 | ||
| 13G/A | Vanguard Group Inc | 7.01 | -37.23 | |
| 13G/A | BlackRock Inc. | 9.20 | -13.98 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 11,882 | 168,732 | 7.04 | |
| 10,828 | 119,098 | 9.09 | |
| 7,136 | 50,438 | 14.15 | |
| 5,001 | 60,985 | 8.20 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| STRO – Sutro Biopharma, Inc. | SUPN – Supernus Pharmaceuticals, Inc. |
| TARA – Protara Therapeutics, Inc. | TCRX – TScan Therapeutics, Inc. |
| TKNO – Alpha Teknova, Inc. |
Financial data and stock pages provided by
Fintel.io